8-K: Aehr Test Systems Reports Fiscal 2025 Third Quarter Revenue Growth and Solid Bookings

Aehr Test Systems announces revenue growth and strong bookings for Q3 2025, but withdraws full-year guidance due to tariff uncertainty.

Summary

• Aehr Test Systems reported its financial results for the third quarter of fiscal year 2025, which ended on February 28, 2025.
• Net revenue for the quarter was $18.3 million, compared to $7.6 million in the third quarter of fiscal 2024.
• The company experienced a GAAP net loss of $(0.6) million, or $(0.02) per diluted share, compared to a GAAP net loss of $(1.5) million, or $(0.05) per diluted share, in the third quarter of fiscal 2024.
• Non-GAAP net income was $2.0 million, or $0.07 per diluted share, compared to a non-GAAP net loss of $(0.9) million, or $(0.03) per diluted share, in the third quarter of fiscal 2024.
• Bookings for the quarter were $24.1 million.
• Backlog as of February 28, 2025, was $18.2 million, with an effective backlog of $21.8 million including bookings since February 28, 2025.
• Total cash, cash equivalents, and restricted cash as of February 28, 2025, was $31.4 million, compared to $35.2 million as of November 29, 2024.
• For the first nine months of fiscal 2025, net revenue was $44.9 million, compared to $49.6 million in the first nine months of fiscal 2024.
• The GAAP net loss for the first nine months was $(1.0) million, or $(0.03) per diluted share, compared to GAAP net income of $9.3 million, or $0.31 per diluted share, in the first nine months of fiscal 2024.
• Non-GAAP net income for the first nine months was $4.8 million, or $0.16 per diluted share, compared to non-GAAP net income of $11.0 million, or $0.37 per diluted share, in the first nine months of fiscal 2024.
• Cash used in operating activities was $5.1 million for the first nine months of fiscal 2025.
• The company has temporarily withdrawn its fiscal year 2025 guidance due to ongoing tariff uncertainty.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive due to strong revenue growth and bookings, but tempered by the GAAP net loss and withdrawal of guidance due to tariff uncertainty.

Positives

• Revenue increased significantly in Q3 2025 compared to Q3 2024.
• Bookings were strong for the quarter.
• The company is successfully diversifying its customer base and entering new markets such as AI processors and GaN semiconductors.
• Aehr shipped the world's first production WLBI systems for AI processors.
• The company is expanding its WLBI offering for SiC to support high-voltage testing across up to 18 wafers.

Negatives

• The company experienced a GAAP net loss in Q3 2025 and for the first nine months of fiscal 2025.
• Cash used in operating activities was $5.1 million for the first nine months of fiscal 2025.
• Revenue for the first nine months of fiscal 2025 was lower than the same period in fiscal 2024.

Risks

• The company has temporarily withdrawn its fiscal year 2025 guidance due to ongoing tariff uncertainty.
• Secondary effects of tariffs on customers could lead to pauses or delays in orders, shipments, or supply chain deliveries.
• The company faces risks and uncertainties described in its Form 10-K, 10-Q, and other SEC filings.

Future Outlook

Aehr Test Systems has temporarily withdrawn its fiscal year 2025 guidance due to ongoing tariff uncertainty but feels positive about its business due to customer forecasts and success in adding new markets and customers.

Management Comments

• Gayn Erickson, President and CEO, stated that the company has been laser-focused on expanding its total addressable markets, diversifying its customer base, and developing new products and capabilities.
• He highlighted the significant progress made in expanding into new key markets and unlocking new opportunities to attract customers and drive revenue growth.
• He noted the diversification of markets and customers beyond silicon carbide WLBI, with AI processors burn-in representing over 35% of the business.
• He expressed excitement about the expansion into new customers and markets, while also believing the company is well-positioned to continue growing its business in the silicon carbide WLBI market.

Industry Context

Aehr's expansion into AI processor testing and burn-in aligns with the growing demand for high-performance computing and AI applications. The company's focus on silicon carbide and GaN semiconductors also positions it to benefit from the increasing adoption of these materials in electric vehicles, power infrastructure, and other industrial applications.

Comparison to Industry Standards

• Aehr's focus on wafer-level burn-in (WLBI) for silicon carbide (SiC) and gallium nitride (GaN) aligns with the industry's increasing demand for high-reliability power semiconductors, similar to companies like Microchip Technology and Infineon Technologies who are also investing in advanced testing solutions.
• The company's expansion into AI processor testing positions it to compete with companies like Teradyne and Advantest, which offer testing solutions for high-performance computing devices.
• Aehr's development of the FOX-XP system with increased wafer capacity (up to 18 wafers) demonstrates a commitment to improving testing throughput and reducing costs, a key competitive factor in the semiconductor test equipment market.

Stakeholder Impact

• Shareholders may experience short-term uncertainty due to the withdrawal of fiscal year 2025 guidance.
• Employees may benefit from the company's expansion into new markets and the potential for future growth.
• Customers may benefit from the company's innovative testing solutions and its focus on high-reliability semiconductors.

Next Steps

• Aehr Test Systems will reassess its guidance policy as clarity develops regarding the impact of tariffs.
• The company will host a conference call and webcast to discuss its third quarter fiscal 2025 operating results.

Key Dates

Keywords

Aehr Test Systems, semiconductor test, burn-in equipment, wafer level burn-in, AI processors, silicon carbide, GaN, FOX-XP, Sonoma, financial results